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ABSTRACT
Pulmonary hypertension (PH) due to atrial septal defect (ASD) may cause a 
decline in right ventricle (RV) function. Soluble ST2 isa prognostic biomarker 
for left ventricle dysfunction. However, its role in RV function has not been 
investigated. This study aimed to investigate the association between serum 
soluble ST2 with RV systolic function in patients with ASD–associated PH. This 
was a cross sectional study. Subjects were patients participated in the COHARD-
PH registry performed in Dr. Sardjito General Hospital, Yogyakarta Indonesia. 
The patients with ASD and PH confirmed by right heart catheterization (RHC) 
were enrolled in this study. The soluble ST2 level was measured in the serum 
collected from pulmonary artery during RHC. Right ventricle systolic function 
was determined by transthoracic echocardiography using peak systolic velocity 
of tricuspid annulus (S’) parameter. This study was performed in 32 adults with 
uncorrected ASD. They predominantly females [n=29 (90.6%)] with median age 
of 31(22.5-44.0) years old. Mean ASD diameter was 2.69±0.53 cm. Median mean 
pulmonary artery pressure (mPAP) 45.0 (36.25-70.0) mmHg. Median soluble 
ST2 level was 23.28 ng/mL. There were no significant correlations between 
soluble ST2 level with S’value (r=0.071; p=0.35), with mPAP (r=0.043; p=0.815), 
with pulmonary vasculer resistance (PVR) (r=0.025; p=0.893) and with right 
ventricle (RV) diameter (r=0.200; p=0.273). Soluble ST2 level was found higher 
in subject with RV dysfunction but not statistically significant. In conclusion, 
serum soluble ST2 level did not associate with RV systolic function, measured 
by S’, in adult ASD-associated PH. 
ABSTRAK
Hipertensi paru (HP) akibat defek septum atrium (DSA) dapat menyebabkan 
penurunan fungsi ventrikel kanan. ST2 terlarut adalah biomarka prognostik 
untuk disfungsi ventrikel kiri, namun perannya pada fungsi ventrikel kanan 
belum diteliti. Tujuan penelitian ini adalah menyelidiki hubungan antara 
ST2 terlarut serum dengan fungsi sistolik ventrikel kanan pada pasien HP-
yang terkait DSA. Penelitian ini merupakan penelitian potong lintang. Subjek 
adalah partisipan register COHARD-PH yang dilakukan di RSUP Dr. Sardjito, 
Yogyakarta, Indonesia. Pasien dengan DSA dan HP yang dikonfirmasi dengan 
penyadapan jantung kanan diikutkan dalam penelitian ini. Kadar ST2 terlarut 
diukur dari serum yang diambil dari arteri paru selama penyadapan jantung 
kanan. Fungsi sistolik ventrikel kanan ditentukan dengan pemeriksaan 
ekhokardiografi transthoraks menggunakan parameter kecepatan puncak 
sistolik dari anulus trikuspid (S’). Penelitian ini dilakukan pada 32 pasien DSA 
dewasa yang tidak dikoreksi. Sebagian subjek adalah wanita [n=29 (90,6%)] 
dengan median umurnya 31(22,5-44,0) tahun. Rerata diameter DSA adalah 
2,69±0,53 cm. Median tekanan rerata arteri paru adalah (mPAP) 45,0 (36,25-
70,0)mmHg. Median kadar ST2 terlarut adalah 23,28 ng/mL. Tidak terdapat 
korelasi signifikan antara kadar ST2 terlarut dengan nilai S’ (r=0.071; p=0.35), 
dengan rerata tekanan arteri paru (mPAP) (r=0,043; p=0,815), dengan tahanan 
vaskular paru (PVR) (r=0,025; p=0,893) dan dengan diameter ventrikel kanan 
(RV) (r=0,200; p=0,273). Kadar ST2 terlarut lebih tinggi pada subjek dengan 
disfungsi RV, namun tidak bermakna secara statistik. Dapat disimpulkan, 
kadar ST2 terlarut serum tidak berhubungan dengan fungsi sistolik ventrikel 
kanan, yang diukur dengan S’, pada pasien HP-terkait DSA dewasa. 
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INTRODUCTION
Atrial septal defect (ASD) is one of 
the most common adult congenital heart 
disease (CHD). It was estimated that the 
prevalence is about 1.6 per 1,000 birth.1 
There are three types of ASDs, among 
them is secundum type ASD which occurs 
in 75% of overall ASD cases.1 In ASD, 
the chronic left-to-right shunt through 
septal defect gives rise to chronic volume 
overload in the right ventricle (RV) and 
blood overflow in pulmonary circulation. 
Eventually, pulmonary artery pressure 
elevates and pulmonary hypertension 
(PH) ensues.
Pulmonary hypertension is a 
vasculopathy disorder in which 
there is a progressive increase in 
pulmonary vascular resistance that 
lead to RV dysfunction.2   Itis  a  frequent 
complication of CHD, especially CHD 
with left-to-right shunt, such as ASD. 
The prevalence of PHin uncorrected 
ASD patients is 5-10%.3  The RV function 
determines the prognosis in patients with 
ASD-associated PH. The structure and 
function of RV is not only an indicator of 
the severity and chronicity of PH but also 
an indicator of severity of underlying 
disease. The RV dysfunction decreased 
life expectancy of ASD-associated PH.4
Several clinical conditions associated 
with myocardial strains, such as volume 
or pressure overload, dilatation of 
the heart chamber, valvular heart 
disease, or increased pulmonary artery 
pressure, increase soluble suppression 
of tumorigenicity-2 (ST2) levels.5 Recent 
studies have focused on the role of 
soluble ST2 on left heart failure. There is 
only a few studies investigate the soluble 
ST2 level in right heart failure induced by 
PH. A study found that circulating soluble 
ST2 level increased in PH patients and 
was associated with RV dilatation as well 
as systolic dysfunction.6  Soluble ST2 level 
not only reflects left ventricular function 
but also the degree of right heart failure, 
as occurs in patients with PH.6,7  However, 
the association of soluble ST2 level with 
RV systolic function in ASD-associated PH 
has not yet confirmed. This study aimed 
to investigate the association between 
soluble ST2 level from pulmonary artery 




The study design was cross sectional. 
The subjects were patients registered in 
the Congenital HeARt Disease in adult 
and Pulmonary Hypertension (COHARD-
PH) registry, Yogyakarta, Indonesia 
whom recruited between January 2017 
and April 2018 period.8 The inclusion 
criteria of this study were1) adult (≥ 18 
years old) uncorrected secundum ASD; 2) 
patients had been undergone right heart 
catheterization (RHC) and confirmed 
PAH, and 3) patients had sinus rhythm 
in electrocardiogram. The exclusion 
criteria of this study were 1) patients 
with history of myocardial infarction; 2) 
patients with impaired left ventricular 
systolic function; 3) patients have 
significant valve diseases; 4) patients 
have lung diseases (asthma bronchial, 
chronic obstructive and restrictive lung 
diseases, and post lung tuberculosis); 
5) patients with diabetes mellitus; 6) 
patients with chronic renal disease, and 
7) patients with a history of malignancy.
Protocol of study
The diagnosis of ASD and 
probability of PH was screened by 
transthoracic echocardiography 
(TTE) and/or transoesophageal 
echocardiography (TOE). The TTE and 
TEE were performed by experienced 
sonographers and the results were 
confirmed by cardiologist consultants 
using the VIVID7 Echo machine (G.E, 
USA). The echocardiographic data was 
stored digitally in the form of discs to 
be analyzed offline from workstation 
computers using Echo-Pac (G.E, USA) 
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software by cardiologist consultants. 
The parameters analyzed were ASD 
diameter, right atrium (RA) diameter, RV 
diameter, transvalvular gradient (TVG) 
and tricuspid regurgitation (TR) severity. 
The RV systolic function was measured 
from apical 4-chamber view with 
Tissue Doppler mode to analyze peak 
systolic velocity of tricuspid annulus (S’) 
parameter. The RV systolic dysfunction 
was determined if the S’ value <10cm/
second.
The hemodynamic assessment 
was performed with RHC examination 
using right femoral vein access. The 
parameters assessed include mean 
pulmonary artery pressure (mPAP), 
pulmonary vascular resistance (PVR), 
flow ratio (FR), mean aortic pressure 
(mAoP) and right ventricle systolic 
pressure (RVSP). The diagnosis of PH 
was based on mPAP value ≥25 mmHg 
and pulmonary artery wedge pressure 
(PAWP) value ≤15 mmHg.9
Blood samples for measurement of 
circulating ST2 level were with drawn by 
catheter placed in the pulmonary artery 
during RHC. The 2 mL blood volume were 
inserted into EDTA tube and centrifuged 
at 4,000 rpm for 10 min at 25oC. The 
supernatan was pipetted and aliquoted 
in a polypropylene tube. The tube was 
stored at -80°C  freezer until analyzed. 
The sample was thawed once just before 
it was analyzed. The circulating ST2 levels 
were measured with a cassette-based 
immunofluorescence imaging method 
(cartridge) using the principle of lateral 
flow immunoassay technology. This test 
used ASPECT-PLUS™ ST2 Test tapes and 
was analyzed with an ASPECT READER™ 
(Critical Diagnostics, USA) tool like 
previously described.10 The measured 
sST2 was expressed in concentration (ng/
mL).
All participants in this study were 
given an informed consent. The ethics 
committee of Faculty of Medicine, 
Public Health and Nursing Universitas 
Gadjah Mada, Yogyakarta, Indonesia had 
approved the study protocol. 
Statistical analysis
Statistics   analysis   was   performed 
with SPSS software version 16.0 (SPSS 
Inc., Chicago, IL). For continuous data, 
the data normality test was performed by 
Saphiro-Wilk test. Normally distributed 
data were presented as mean ± standard 
deviation (SD), not normally distributed 
data were presented in the median and 
interquartile range (Q1-Q3). Categorical 
variables were presented in proportion. 
Pearson correlation test was performed 
to determine the correlation coefficient 
between two normally distributed 
variables, while Spearman correlation 
test  for  data  with  not  normal 
distribution. The mean difference 
between the two groups was analyzed 
using the student-t or Mann Whitney 
test. A p value <0.05 was considered 
statistically significant.
RESULTS
A total of 32 subjects were enrolled 
in this study. The characteristics of the 
subjects are presented in TABLE 1. The 
majority of the subjects were females 
(90.6%) with a median age of 31 (22.5-
44.0) years old. From RHC examination, 
median mPAP was 45.0 (36.25-70.0) 
mmHg and mean mAoP equal to 102.0 
± 14.75 mmHg. The mean FR was 2.69± 
2.01, median PVR was 5.25 (1.88-12.68) 
Wood unit and mean RVSP was 80.63± 
29.32 mmHg. The median value of serum 
ST2 level from pulmonary artery was 
23.28 (18.80-33.55)ng/mL.
From the echocardiography 
examination, the mean diameter of ASD 
defect was 2.69 ± 0.53 cm, the median RA 
diameter was 4.70 ± 0.55cm, the meanRV 
diameter was 4.74 ± 0.54 cm, and the 
mean TVG was 68.84 ± 32.45mmHg. The 
degree of TR varied in the subjects, with 
10 subjects had mild degree (31.3%), 
moderate degree in 11 (34.4%) subjects, 
and severe degree in 11 (34.4%) subjects. 
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•	 Male 2 (9.4)
•	 Females 29 (90.6)
Age [media (Q1-Q3) year] 31 (22.5-44.0)
Body Surface Are (mean ± SD year) 1.40 ± 0.16
Echocardiography parameter
•	 ASD defect diameter (mean ± SD cm) 2.69 ± 0.53
•	 RA diameter (mean ± SD cm) 4.83 ± 0.55
•	 RV diameter (mean ± SD cm) 4.74 ± 0.50
•	 S’ (mean ± SD cm/s) 13.72 ± 3.69
•	 TVG (mean ± SD mmHg) 68.84 ± 32.45
•	 TR severity [n (%)]
•	 Mild 10 (31.3)
•	 Moderate 11 (34.4)
•	 Severe 11 (34.4)
•	 LV ejection fraction (mean ± SD %) 73.94 ± 7.80
Hemodynamic parameter by RHC
•	 mPAP [median (Q1-Q3) mmHg] 45.0 (36.25-70.0)
•	 mAoP(mean ± SD mmHg) 102.0 ± 14.75
•	 FR (mean ± SD) 2.69 ± 2.01
•	 PVR [median (Q1-Q3) Woods unit] 5.25 (1.88-12.68)
•	 RVSP (median ± SD mmHg) 80.63 ± 29.32
PH-targeted therapy
•	 Seldenafil [n (%)] 11 (34.4)
•	 Beraprost [n (%)] 5 (15.6)
Serum sST2 (ng/mL); median (Q1-Q3) 23.28 (18.80-33.55)
ASD: atrial septal defect, RA: right atrium, RV: right ventricle, TVG: tri-
cuspid valve gradient; TR: tricuspid regurgitation, LV: left ventricle, 
mPAP: mean pulmonary artery pressure, mAoP: mean aortic pressure, 
FR: flow ratio, PVR: pulmonary vascular resistance;RVSP: right ventri-
cle systolic pressure, PH: pulmonary hypertension
From Spearman correlation test, it 
was found that serum ST2 level did not 
correlate with S’ value (r = 0.071; p = 
0.35) (FIGURE1). In addition, the serum 
ST2 level did not correlate with age (r 
=0.098; p =0.054), defect diameter (r 
=0.010; p =0.955), RA diameter (r =0.041; p 
=0.823), RV diameter (r =0.025; p =0.893), 
FR (r =0.025; p =0.893), PVR (r =-0.025; 
p =0.273), TVG (r =-0.041; p =0.824), and 
RVSP (r =-0.024; p =0.262).
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FIGURE 1. The scatter-plot of correlation between soluble 
ST2 and S’ value (r = 0.071; p = 0.35). 
The analysis was performed 
by categorizing subjects into 2 group, 
i.e. subjects with RV dysfunction and 
subject with normal RV function. The 
RV dysfunction was defined by value 
S’ <10cm/sec. There was significant 
difference between these 2 groups in 
term of mean RVSP (99.71±33.42vs. 
75.28±26.36 mmHg; p=0.050), median 
mPAP (72.0(34–91) vs. 43.0 (30–79) 
mmHg; p=0.032), and median PVR 
(30.19(3.1–56.28)vs. 5.31 (2.37–12.64) 
Wood unit; p=0.034), respectively. Serum 
ST2 level was higher in subjects with RV 
dysfunction as compared with subjects 
with normal RV function but statistically 
not significant (median: 24.97 (21.68-
38.7)ng/mL vs. 21 (17.36-33.28) ng/mL; 
(p=0.284) (TABLE 2).
TABLE 2. The comparison of characteristic of adult secundum atrial septal defect-










Age (years) 25 (21-41) 34 (23-45.5) 0.373*
Echocardiography Parameter 
•	 Defect diameter (mean ± SD cm) 2.64± 0.66 2.67±0.50 0.887
•	 RV diameter (mean ± SD cm) 4.87± 0.54 4.71±0.49 0.466
Hemodynamic parameter by RHC
•	 RVSP (mean ± SD mmHg) 99.71±33.42 75.28±26.36 0.050
•	 mPAP(mean ± SD mmHg) 72.0(34-91) 43.0(30-79) 0.032*
•	 PVR  [median (Q1-Q3) Woods unit] 30.19 (3.1–56.28) 5.31 (2.37–12.64) 0.034*
•	 FR (mean ± SD) 1.54±0.50 3.0±2.0 0.088
Serum sST2 (mean ± SD ng/mL) 24.97 (21.68-38.70) 21.0(17.36-33.28) 0.284*
*Nonparametric data and  analyze with Mann-Whitney test; RV: right ventricle; RVSP:right 
ventricle systolic pressure; mPAP: mean pulmonary arterial pressure; PVR:pulmonary 
vascular resistance; FR: flow ratio
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The correlation between parameters 
with S’ value was shown in TABLE 3. 
The mPAP and PVR had a significantly 
strong and negative correlation with S’ 
value (r =-0.661; p <0.001) and (r =-0.568; 
p =0.001), respectively.
TABLE 3. The correlation between 


















In this study, the serum sST2 level 
from pulmonary artery did not associate 
with RV systolic function. There was 
a tendency toward increased serum 
sST2 level from pulmonary artery in 
subjects with RV systolic dysfunction. 
The mPAP and PVR value influenced 
the RV systolic dysfunction. There was 
an inverse correlation   between   mPAP 
and PVR value with S’ value, indicated 
the association between increased 
pulmonary artery pressure and 
resistance with reduced RV function.
In the secundum ASD population, 
females dominates as much as 65-75% 
of the population.3 This is similar to this 
study in which females predominates, 
90.6%. According to the registers in 
Europe, the mean age of ASD patients 
was 36 years old.11,12 This was consistent 
with this study in which the median age 
of this study subjects was about 30 years. 
There is a timespan from asymptomatic 
to symptomatic phase of ASD due to 
complication PH. In the COHARD-PH 
registry, most patients with ASD did not 
diagnosed properly in childhood and 
consequently develop complication of 
PH, Eisenmenger syndrome and right 
heart failure.8
This study was the first to assess 
the association between serum sST2 
level, taken from pulmonary artery, 
with S’ parameter in ASD-associated 
PH. Previous  research had shown 
a significant correlation between 
serum sST2 with RV systolic function 
parameters,i.e Tricuspid Annular 
Plane Systolic Excursion (TAPSE) and 
Right Ventricle Fractional Area Change 
(RVFAC), in the PH subjects population 
due to chronic obstructive pulmonary 
disease.13 Other studies with PH 
population due to various etiologies, 
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found that sST2 levels were associated 
with RV systolic function measured by 
cardiac magnetic resonance imaging.13 
Our results differ from those previous 
studies, in which serum sST2 were not 
significantly correlated with RV systolic 
function parameters, by S’ value. The 
serum sST2 level also did not discriminate 
subjects with RV dysfunction.
The difference in the results of this 
study compared with previous studies 
may be due to different RV adaptation 
responses in two different populations. 
The RV adaptive response to shunt of CHD 
is quite good as compared to idiopathic 
PAH or PH due to other causes.4 One 
study found that RV dilatation and rapid 
decline in RV systolic function are more 
common in patients with idiopathic 
PAH or PH-associated with pulmonary 
disease or connective tissue disease. In 
contrast, the decrease in RV function 
occurs much more slowly in patients 
with ASD-associated PH.14,15
This study has several limitations, 
i.e. the subjects sample size is small and 
the parameter of RV systolic dysfunction 
is only one parameter i.e. S’ by TTE. 
Further large study need to be performed 
to corroborate or contradict the result of 
this study.  However, our result suggests 
that sST2 is not a good biomarker to detect 
RV function especially in ASD-associated 
PH patients. Our previous data indicated 
that other strained biomarker, i.e. 
N-terminal pro brain natriuretic peptide, 
is performed better in predicting PH 
severity, RV pressure overload and RV 
systolic function in adult patients with 
ASD.16 Future direction needs to be 
addressed is to test the other potential 
biomarkers for RV function in patients 
with PH.
CONCLUSION
In conclusion, there is no association 
between serum sST2 levels from 
pulmonary artery with systolic RV 
function in secundum ASD-associated 
PH patients.
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